Literature DB >> 6104355

Inhibition of gastric secretion in man with a new H2-receptor antagonist, ranitidine.

K Kett, E Aadland, A Berstad.   

Abstract

Inhibition of pentagastrin-evoked gastric secretion of acid and pepsin by cimetidine and a new H2-receptor antagonist, ranitidine, was compared in nine healthy young subjects. On separate days cimetidine or ranitidine was administered by continuous intravenous infusions in graded doses. The results demonstrated that the inhibitory effect of ranitidine was 6 and 7.3 times as potent as cimetidine on a weight and a molar basis, respectively.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6104355     DOI: 10.3109/00365528009181464

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  9 in total

1.  pH-feedback controlled infusions of ranitidine are no more effective than fixed-dose infusions in reducing gastric acidity and variability in antisecretory responses.

Authors:  C H Wilder-Smith; F Halter; W Häcki; H S Merki
Journal:  Br J Clin Pharmacol       Date:  1992-05       Impact factor: 4.335

2.  Influence of ranitidine on hepatic blood flow assessed by organ-reflectance spectrophotometer and pulse-Doppler ultrasonic flowmeter.

Authors:  Y Sasaki; N Hayashi; A Kasahara; Y Matsuda; S Furusawa; H Fusamoto; N Sato; T Kamada
Journal:  Dig Dis Sci       Date:  1985-11       Impact factor: 3.199

3.  Gastro-oesophageal function in normal subjects after oral administration of ranitidine.

Authors:  L Wallin; T Madsen; S Boesby
Journal:  Gut       Date:  1983-02       Impact factor: 23.059

4.  Comparative trial of the effect of ranitidine and cimetidine on gastric secretion in fasting patients at induction of anaesthesia.

Authors:  J M Durrant; L Strunin
Journal:  Can Anaesth Soc J       Date:  1982-09

Review 5.  Ranitidine: a review of its pharmacology and therapeutic use in peptic ulcer disease and other allied diseases.

Authors:  R N Brogden; A A Carmine; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1982-10       Impact factor: 9.546

6.  Comparison of twice-daily ranitidine with standard cimetidine treatment of duodenal ulcer.

Authors:  R P Walt; I F Trotman; R Frost; P L Golding; T H Shepherd; J Rawlings; R H Hunt; D Colin-Jones; G J Milton-Thompson; J J Misiewicz
Journal:  Gut       Date:  1981-04       Impact factor: 23.059

7.  H2-receptor antagonists protect against aspirin-induced gastric lesions in the rat.

Authors:  K T Bunce; M J Daly; J M Humphray; R Stables
Journal:  Agents Actions       Date:  1981-04

8.  Effect of H2-receptor blockade by ranitidine on ulcer healing and gastric acid secretion in patients with gastric and duodenal ulcers.

Authors:  H Forssell; G Koch
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

9.  Ranitidine and duodenal ulceration: a short-term and maintenance study.

Authors:  R Sheers; J S McKay; S Hughes
Journal:  J R Soc Med       Date:  1982-05       Impact factor: 18.000

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.